PTGS2 and Alzheimer disease: In the AD-only group, the COX-2 expression level was 56% higher than in the CON group; AA treatment (AD + AA-L and AD + AA-H groups) decreased COX-2 expression (47% and 59%, respectively) compared to the AD-only group.